In the latest episode of #OptimumTV, 4SC AG’s CEO Jason Loveridge talks about the company’s plans to bring its drug resminostat to market for the treatment of CTCL, a type of non-Hodgkin’s lymphoma that affects the skin.
Optimum Strategic Communications
Public Relations and Communications Services
London, London 1,609 followers
International Strategic Healthcare Communications
About us
Optimum is an international strategic communications firm specialising in investor relations, corporate and financial communications. Our team of healthcare specialists, based in London and New York, have worked together for many years. Our first-hand experience of analysing, investing and writing about healthcare companies uniquely positions us when advising our clients on building a compelling investment story. Subscribe to our Optimum Perspectives Podcast, where we host industry leaders, and highlight the latest innovation and developments in life sciences. Listen here now: https://www.optimumcomms.com/podcast/
- Website
-
http://www.optimumcomms.com
External link for Optimum Strategic Communications
- Industry
- Public Relations and Communications Services
- Company size
- 11-50 employees
- Headquarters
- London, London
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Investor Relations, Financial Communications, Media Relations, Healthcare, Life Sciences, Corporate Communications, and Public Relations
Locations
-
Primary
Get directions
8 Devonshire Square
London, London EC2M 4YP, GB
Employees at Optimum Strategic Communications
Updates
-
From plant-based fungi food to an #award to develop a potential disease-modifying therapy for #Parkinson’s disease, here’s what our clients have been up to this week #OptimumStrategicCommunications #LifeSciences
-
Great to see our client STORM Therapeutics Limited and Matthew Fyfe at #ONHelix24 today where he shared his experience from the One Nucleus Boston Bootcamp earlier this year. Matthew detailed his learnings and how the UK differs from the US, particularly in terms of funding and investment in the #biotech infrastructure in Massachusetts, Boston.
-
-
Amir Hefni presented Resolution Therapeutics as ‘a company to watch’ detailing the innovative modality the Company is using at #ONHelix2024. Amir also took part in the ‘New Horizons for Therapeutic Modalities’ #panel discussing the importance of early conversations to speed up optimisation with CROs and with the FDA/MHRA. Very exciting things to come for our client, whose novel approach in developing macrophage cell therapies aims to treat #diseases characterised by life-threatening #inflammatory organ diseases.
-
-
One Nucleus' #OnHelix conference is this Thursday! Optimum Strategic Communications is a proud supporter of One Nucleus events and is happy to share an exclusive 10% F&F discount. Please get in touch if you would like to optimise this or connect with the team there! #OptimumStrategicCommunications #OnHelix24
-
-
From an investment in AI-based solutions for sustainable #agriculture to new data from hepatocellular carcinoma therapy, here’s what Optimum and its clients have been up to this week! #OptimumStrategicCommunications #Biotech #LifeSciences
Congratulations to Verona Pharma on securing FDA approval of COPD maintenance therapy Ohtuvayre (ensifentrine)
Optimum Strategic Communications on LinkedIn
-
The death cap mushroom is feared throughout the world because of the deadly toxin it contains, amanitin. But our client Heidelberg Pharma AG thinks amanitin could be used to fight cancer - find out more in our latest feature. #cancer #pharma #mushrooms
Death cap poison: the latest weapon in the fight against cancer
Optimum Strategic Communications on LinkedIn
-
📺 Watch our latest episode of #OptimumTV, in which Stefano Gullà, CSO of Amsterdam-based Kling Biotherapeutics, describes how Kling is creating exceptional antibody-based drugs by interrogating the #immune responses of ‘elite responders’ to #disease.
-
From a Knighthood for STORM Therapeutics Limited’s founder Sir Tony Kouzarides, to an €80 million Series B financing, here’s what Optimum and its clients have been doing this week! #OptimumStrategicCommunications #biotech #financing #lifesciences
Tony Kouzarides, Founder of STORM Therapeutics, Awarded British Knighthood for Services to Healthcare Innovation and Delivery
Optimum Strategic Communications on LinkedIn
-
How is it only 4 months until Optimum Strategic Communications' 16th Annual #Healthcare #Investor Conference? Just as well the #agenda is shaping up nicely! We are thrilled to announce our first fireside chat featuring Clive Cookson of Financial Times and Dr. Mehmood Khan, CEO of Hevolution Foundation. Hevolution is headquartered in Riyadh and supports a cutting-edge, global ecosystem of talent to propel aging and geroscience research forward and achieve medical breakthroughs to help humanity live healthier, longer. Over the last 18 months, Hevolution has committed over $360M+ in funding, with more to come. #OptimumStrategicCommunications #OptimumConference2024
-